Financing, Equity Capital Markets

Cogent Biosciences

06/23
|
$150.0 Million
Cogent
Piper Sandler served as bookrunner for Cogent Biosciences on a confidentially marketed follow on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Biopharma